RADX Radiopharm Theranostics: Company Short-Term Debts

Symbol and logo of brand Radiopharm Theranostics (RADX)

Radiopharm Theranostics (RADX) possesses significant market influence due to its unique nanoparticles for targeted tumor therapy. However, isotope logistics complexities and liquidity shortages create serious financial threats. The dynamics of current liabilities demonstrate a shift in credit strategy, with the indicator value reaching 0.00. Simultaneously, the company is steadily expanding its production capacities and synthetic laboratories.

RADX radiopharmtheranostics.com Company Short-Term Loans and Borrowings (12/06/2024 - 10/31/2026)

RADX (Radiopharm Theranostics Ltd): analytical breakdowns and indicator data

- stock price and consensus target price:
Stock Price Radiopharm Theranostics Limited|RADX - Consensus Target
- company stock capitalization data:
Market Capitalization Radiopharm Theranostics Limited|RADX - Total Enterprise Value
- business book valuation details:
Net Assets per Single Share Radiopharm Theranostics|RADX - Accounting Value of Company|Market Cap to Net Assets Ratio radiopharmtheranostics.com|RADX - Aggregate Asset Value
- debt and liquidity details:
Total Debt to Capital Radiopharm Theranostics|RADX - Long-Term Debt to Equity Ratio|Short-Term Debt to Equity Ratio Radiopharm Theranostics|RADX - Company Aggregate Debts|Debt to Book Capitalization Ratio Radiopharm Theranostics Limited|RADX - Company Long-Term Loans and Borrowings|Company Short-Term Debts Radiopharm Theranostics|Quick Liquidity radiopharmtheranostics.com
- earnings and multiples data:
RADX - Final Profit
Analysis of all company metrics:RADX - Radiopharm Theranostics Limited
Manufactured products of radiopharmtheranostics.com

Short-term debt measures the volume of obligations with a maturity horizon of up to one year, allowing for an assessment of liquidity risk and the business's dependence on external borrowings. By analyzing the short-term debt balance, an investor determines the financial autonomy of Radiopharm Theranostics (RADX), which is critical for sustaining costly developments in theranostics and the implementation of precision isotopic oncology treatments.

Competing companies

BeiGene - Company Short-Term Debts|Halozyme Therapeutics, Inc. (HALO) - Company Current Liabilities|RVMD: Company Short-Term Debts|Short-Term Debt Ascentage Pharma Corp (AAPG)|Company Short-Term Debt CG Oncology, Inc.|URGN: Company Short-Term Loans and Borrowings|Company Current Liabilities BCAX (Bicara Therapeutics)|PSNL (Personalis Inc) - Company Short-Term Loans and Borrowings|Company Short-Term Debts ERAS (Erasca Corp)|DCTH - Company Current Liabilities|YMAB: Company Current Liabilities|AURA - Company Short-Term Debts|candeltx.com (CADL) - Company Short-Term Debt|Accuray Inc - Company Short-Term Loans and Borrowings|SLS (SELLAS Life Sciences Group, Inc.) - Company Short-Term Debts|Short-Term Debt Actuate Therapeutics Inc ACTU|Company Short-Term Debt Citius Oncology, Inc. (CTOR)|HURA (tuhurabio.com) - Company Short-Term Loans and Borrowings|Company Short-Term Debts TARA (Protara Therapeutics, Inc.)|Company Short-Term Debts Fate Therapeutics Inc FATE|Aadi Bio - Company Short-Term Debts|TCRX (TScan Therapeutics) - Company Short-Term Indebtedness|CSBR: Company Short-Term Debts|XBIT - Short-Term Debt Volume|Company Short-Term Debt CEL-SCI Corp.|Short-Term Debt OS Therapies Inc. OSTX|Company Short-Term Debt Artiva Biotherapeutics, Inc. (ARTV)|ANL: Current Liabilities|Company Short-Term Debts VERU (Veru Inc.)|Company Short-Term Loans and Borrowings TPST|Xilio - Company Short-Term Debts|RENB - Company Short-Term Debts|muraloncology.com (MURA) - Company Short-Term Debt|Kairos Pharma - Company Short-Term Loans and Borrowings|Company Short-Term Debt OnKure Therapeutics, Inc.|Company Current Liabilities CytoMed (GDTC)|Company Current Liabilities CRIS (Curis, Inc.)|APLM (apollomicsinc.com) - Company Short-Term Loans and Borrowings|Tharimmune Corp - Company Current Liabilities|Amount of Current Liabilities ADVB (Advanced Biomed Inc.)|Genprex, Inc. - Company Short-Term Debts|Company Short-Term Loans and Borrowings CLDI (Calidi Biotherapeutics)|SBFM: Company Short-Term Debts|Short-Term Debt Xenetic Biosciences, Inc. (XBIO)|Company Short-Term Debt Salarius|PPBT: Company Short-Term Loans and Borrowings|Company Short-Term Debts AONC|Company Short-Term Debts beigene.com (BGNE)|Company Short-Term Debt Checkpoint Therapeutics, Inc. CKPT|ELEV: Company Short-Term Indebtedness|ICAD - Company Short-Term Debt|Short-Term Debt Ikena Oncology, Inc.|Notable Labs, Ltd. (NTBL) - Company Short-Term Debt|VIRX - Short-Term Debt Volume|Company Current Liabilities MOR|NAYA (NAYA Biosciences Inc) - Amount of Current Liabilities|Company Short-Term Debts AAPGV